Farmaco (Societa chimica italiana : 1989)最新文献

筛选
英文 中文
Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices 热处理对Eudragit RS基体影响的机理评价
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.07.009
Shirzad Azarmi , Fatemeh Ghaffari , Raimar Löbenberg , Ali Nokhodchi
{"title":"Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices","authors":"Shirzad Azarmi ,&nbsp;Fatemeh Ghaffari ,&nbsp;Raimar Löbenberg ,&nbsp;Ali Nokhodchi","doi":"10.1016/j.farmac.2005.07.009","DOIUrl":"10.1016/j.farmac.2005.07.009","url":null,"abstract":"<div><p>Thermal treatment of acrylic matrices was recently introduced as a tool for prolonging the release of drug. Thermal treatment at temperatures above the T<sub>g</sub><span><span> of the polymer can decrease drug release rate. In this research we studied the mechanism of the effect of thermal treatment on Eudragit<span> RS matrices. Indomethacin was used as model drug. The results showed that polymer chain movement and redistribution of the polymer in the tablet matrix structure after thermal-treating is the possible mechanism of drug release prolongation. The melting and resolidification of the polymer, due to the thermal treatment has apparently resulted in a redistribution of the polymer throughout the matrix and a change in the porosity of the tablet. </span></span>FTIR<span> results did not show any drug–polymer interaction due to heat-treatment. DSC and PXD studies ruled out the occurrence of solid solution and polymorphic change of the drug.</span></span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 925-930"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.07.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25636446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
New, simple and validated UV-spectrophotometric methods for the estimation of gatifloxacin in bulk and formulations 新的,简单和有效的紫外分光光度法估计加替沙星原料药和制剂
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.08.010
K. Venugopal, Ranendra N. Saha
{"title":"New, simple and validated UV-spectrophotometric methods for the estimation of gatifloxacin in bulk and formulations","authors":"K. Venugopal,&nbsp;Ranendra N. Saha","doi":"10.1016/j.farmac.2005.08.010","DOIUrl":"10.1016/j.farmac.2005.08.010","url":null,"abstract":"<div><p><span><span>New, simple and cost effective UV-spectrophotometric methods were developed for the estimation of gatifloxacin in bulk and pharmaceutical formulations. Gatifloxacin was estimated at 286 nm in 100 mM phosphate buffer (pH 7.4) and 292 nm in 100 mM </span>hydrochloric acid (pH 1.2). Linearity range was found to be 1–18 μg ml</span><sup>–1</sup> (regression equation: absorbance<!--> <!-->=<!--> <!-->0.0684<!--> <!-->×<!--> <!-->Concentration in μg ml<sup>–1</sup> <!-->+<!--> <!-->0.0050; r<sup>2</sup> <!-->=<!--> <!-->0.9998) in the phosphate buffer (pH 7.4) and 1–14 μg ml<sup>–1</sup> (regression equation: absorbance<!--> <!-->=<!--> <!-->0.0864<!--> <!-->×<!--> <!-->Concentraion in μg ml<sup>–1</sup> <!-->+<!--> <!-->0.0027; r<sup>2</sup> <!-->=<!--> <!-->0.9999) in hydrochloric acid medium (pH 1.2). The apparent molar absorptivity was found to be 2.62<!--> <!-->×<!--> <!-->10<sup>4</sup> l mol<sup>−1</sup> cm<sup>−1</sup> in the phosphate buffer and 3.25<!--> <!-->×<!--> <!-->10<sup>4</sup> l mol<sup>−1</sup> cm<sup>−1</sup> in hydrochloric acid media. In both the proposed methods sandell's sensitivity was found to be about 0.01 μg cm<sup>−2</sup>/0.001A. These methods were tested and validated for various parameters according to ICH guidelines and USP. The quantitation limits were found to be 0.312 and 0.3 μg ml<sup>–1</sup> in the phosphate buffer and hydrochloric acid medium, respectively. The proposed methods were successfully applied for the determination of gatifloxacin in pharmaceutical formulations (tablets, injection and ophthalmic solution). The results demonstrated that the procedure is accurate, precise and reproducible (relative standard deviation &lt;<!--> <!-->2%), while being simple, cheap and less time consuming and can be suitably applied for the estimation of gatifloxacin in different dosage forms and dissolution studies.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 906-912"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.08.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25637056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 55
Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation 乙醇和肉豆蔻酸异丙酯二元组合给药紫杉醇的可行性研究:溶解度、分配和脂质双分子层扰动的作用
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.07.004
Ramesh Panchagnula, Hariraghuram Desu, Amit Jain, Sateesh Khandavilli
{"title":"Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation","authors":"Ramesh Panchagnula,&nbsp;Hariraghuram Desu,&nbsp;Amit Jain,&nbsp;Sateesh Khandavilli","doi":"10.1016/j.farmac.2005.07.004","DOIUrl":"10.1016/j.farmac.2005.07.004","url":null,"abstract":"<div><p><span>In the current investigation, paclitaxel<span> (PCL) delivery into the different layers of skin, vehicle optimization and relationship between vehicle composition and the relative contribution of solubility, partition and diffusion towards drug transport has been outlined. Saturation solubility of PCL was determined in ethanol (EtOH), isopropyl myristate (IPM) and their binary combinations, and partition studies performed to study the probability of skin depot formation. Epidermal and dermal partitioning was carried from PCL saturated vehicles. Skin permeation of PCL was studied using the rat skin. FT-IR has been utilized to study the skin barrier perturbation, and the localization of PCL and isopropyl myristate (IPM) in epidermis. High </span></span><em>K</em><sub>app</sub> value in mineral oil/buffer indicated the tendency of PCL to form a reservoir in skin, and an inverse relationship between PCL solubility in different solvent systems and partitioning into epidermis was found. Maximum <em>K</em><sub>epidermis</sub> for PCL was observed with IPM, while PCL in EtOH/IPM (1:1) showed high partitioning into dermis. Maximum flux of PCL was observed with EtOH/IPM (1:1). For lipophilic drug like PCL modulation of vehicle seems to be effective approach to increase the permeability across the skin. With a binary combination of EtOH/IPM (1:1) higher concentration of PCL can be delivered to deeper layer of skin whereas with IPM higher concentration of PCL could be localized in the epidermis. While engineering the delivery vehicle selection of solvents should be such that one of them is miscible in both hydrophilic and lipophilic phase like ethanol and another should be lipophilic in nature (IPM in this case) so that an optimum balance between ‘push–pull’ and ‘blending’ effect can be achieved.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 894-899"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25271746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
Chemical and biochemical transformations of 5-ethoxycarbonyl-5-phenyl-2-isoxazolines 5-乙氧羰基-5-苯基-2-异恶唑啉的化学和生化转化
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.07.003
Irmina Zadrożna , Joanna Kurkowska , Hanna Kruszewska
{"title":"Chemical and biochemical transformations of 5-ethoxycarbonyl-5-phenyl-2-isoxazolines","authors":"Irmina Zadrożna ,&nbsp;Joanna Kurkowska ,&nbsp;Hanna Kruszewska","doi":"10.1016/j.farmac.2005.07.003","DOIUrl":"10.1016/j.farmac.2005.07.003","url":null,"abstract":"<div><p>The salts, 2-methyl-5,5-disubstituted 4,5-dihydroisoxazolium methylsulfates comprising various substituents at the C-3 carbon atom were subjected to transformations. The structure of applied compounds permitted to monitor the effect of this factor on the transformation course of the 2-isoxazoline ring. The nucleophilic addition of cyanide anion to the selected salts enabled the obtaining of a next heterocyclic system of changed physicochemical and biological properties in comparison to the starting 2-isoxazolines. The diastereoselective hydrolysis of the cyanide group in 2-isoxazolidines by the bacteria strain <span><em>Rhodococcus rhodochrous</em></span> PCM 909 leads to the obtaining of a racemic mixture of the <em>trans</em>-hydroxyacid. The introduction of new functional groups into the heterocyclic ring made these compounds attractive objects for further chemical and microbial transformations and to study their biological activity.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 948-954"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25673075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
INDEX MOTS CLES 2005 指数低于2005年
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/S0014-827X(05)00214-4
{"title":"INDEX MOTS CLES 2005","authors":"","doi":"10.1016/S0014-827X(05)00214-4","DOIUrl":"https://doi.org/10.1016/S0014-827X(05)00214-4","url":null,"abstract":"","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 985-996"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0014-827X(05)00214-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91608014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CV2 - Editorial Board CV2 -编辑委员会
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/S0014-827X(05)00207-7
{"title":"CV2 - Editorial Board","authors":"","doi":"10.1016/S0014-827X(05)00207-7","DOIUrl":"https://doi.org/10.1016/S0014-827X(05)00207-7","url":null,"abstract":"","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Page CO2"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0014-827X(05)00207-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136587572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal administration of heparin-loaded microspheres based on poly(lactic acid) 基于聚乳酸的负载肝素微球鼻腔给药
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.08.004
Ayca Yıldız , Alper Okyar , Gül Baktır , Ahmet Araman , Yıldız Özsoy
{"title":"Nasal administration of heparin-loaded microspheres based on poly(lactic acid)","authors":"Ayca Yıldız ,&nbsp;Alper Okyar ,&nbsp;Gül Baktır ,&nbsp;Ahmet Araman ,&nbsp;Yıldız Özsoy","doi":"10.1016/j.farmac.2005.08.004","DOIUrl":"10.1016/j.farmac.2005.08.004","url":null,"abstract":"<div><p>In this study, heparin-loaded microspheres<span><span><span> having smooth surface and small particle size were designed in order to provide the absorption of heparin through nasal mucosa. For this purpose, microspheres at different polymer/drug ratios (1:10, 1:2.5 and 1:1) and at different concentrations of polyvinyl alcohol, </span>emulsifying agent (1.5% and 2.5% w/v) were prepared by solvent evaporation method with poly(lactic acid). The microspheres were for evaluated shape and surface properties, particle size, production yield, encapsulation efficiency and in vitro drug release. Based on the in vitro data, selected microspheres were applied by nasal route to </span>Wistar albino rats. According to in vivo studies, heparin-loaded microspheres may be used by nasal route as an alternative to parenteral route.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 919-924"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25673073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers BCS III类和IV类药物的亲脂性与口服吸收促进剂功能活性的关系
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.08.006
Pradeep Sharma, Manthena V.S. Varma, Harmander P.S. Chawla, Ramesh Panchagnula
{"title":"Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers","authors":"Pradeep Sharma,&nbsp;Manthena V.S. Varma,&nbsp;Harmander P.S. Chawla,&nbsp;Ramesh Panchagnula","doi":"10.1016/j.farmac.2005.08.006","DOIUrl":"10.1016/j.farmac.2005.08.006","url":null,"abstract":"<div><p><span>Absorption enhancers (AEs) have been shown to be specific in permeation enhancement capabilities because of which they increase absorption of some drug molecules more than others. Present study was designed to investigate the relationship between lipophilicity of drug molecules and the absorption enhancement potential of AEs. Four drug molecules of different lipophilicity were selected as model compounds, namely, </span>cefotaxime sodium<span><span>, ceftazidime<span> pentahydrate, lovastatin and </span></span>cyclosporin A.<span> Their apparent permeability coefficients in the absence and presence of three classes of AEs (fatty acids, cyclodextrins, and bile salts) were determined using in vitro everted rat intestinal sac absorption model. Significant relationship was observed between log P of drug and absorption enhancement ratios by AEs. This relationship was found to be functionally directly or indirectly proportional depending upon nature of AE and explain the mechanism of permeation enhancement.</span></span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 870-873"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.08.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25602830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties 具有抗炎和抗肿瘤性质的3-芳基-5-十戊基-1,2,4-恶二唑的合成
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.08.003
Natércia M. Miranda Bezerra , Shalom P. De Oliveira, Rajendra M. Srivastava, Joel R. Da Silva
{"title":"Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties","authors":"Natércia M. Miranda Bezerra ,&nbsp;Shalom P. De Oliveira,&nbsp;Rajendra M. Srivastava,&nbsp;Joel R. Da Silva","doi":"10.1016/j.farmac.2005.08.003","DOIUrl":"10.1016/j.farmac.2005.08.003","url":null,"abstract":"<div><p>A simple, convenient and straightforward synthesis of 3-aryl-1,2,4-oxadiazoles <strong>4a–f</strong> from arylamidoximes <strong>1a–f</strong><span> and palmitic acid </span><strong>2</strong> is described. Compounds <strong>4a–f</strong> are non-lethal in mice at four times the therapeutic dose (i.p., LD<sub>50</sub> <!-->&gt;<!--> <!-->1 g kg<sup>–1</sup><span> of the animals' body weight). These heterocycles have been found to possess antiinflammatory property similar to aspirin and ibuprofen. Three compounds, viz., </span><strong>4a</strong>, <strong>d</strong>, <strong>e</strong><span> have also been evaluated for antitumor activity, where </span><strong>4d</strong><span> exhibited an excellent activity comparable to lapachol.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 955-960"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25663745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 48
A new assay for the discovery of Bcl-XL inhibitors 发现Bcl-XL抑制剂的新方法
Farmaco (Societa chimica italiana : 1989) Pub Date : 2005-11-01 DOI: 10.1016/j.farmac.2005.06.017
Cristina Pisoni , Guido Cimoli , Anna Resconi , Daniele Losi , Rolando Lorenzetti , Silvio Parodi , Lucia Carrano
{"title":"A new assay for the discovery of Bcl-XL inhibitors","authors":"Cristina Pisoni ,&nbsp;Guido Cimoli ,&nbsp;Anna Resconi ,&nbsp;Daniele Losi ,&nbsp;Rolando Lorenzetti ,&nbsp;Silvio Parodi ,&nbsp;Lucia Carrano","doi":"10.1016/j.farmac.2005.06.017","DOIUrl":"10.1016/j.farmac.2005.06.017","url":null,"abstract":"<div><p><span>The Bcl-2 family of antiapoptotic<span> proteins is commonly over expressed in many types of human cancer and remains one of the few validated targets. Antiapoptotic family proteins such as Bcl-2 and Bcl-XL function, at least in part, by binding proapoptotic members such as Bax and Bak and thereby prevent release of the apoptotic cascade of events. “BH3-only” members of the family disrupt this interaction by binding, via their BH3 domain, to a hydrophobic pocket on the surface of the antiapoptotic members. Disruption of heterodimerization could be used to modulate cell death reinstating apoptosis in cancer cells. An affinity displacement assay based on Bcl-XL/BH3 interaction has been developed. This assay makes use of soluble His-tagged Bcl-XL and fluorescein tagged BH3. Binding is measured as fluorescence associated with magnetic beads. The assay was miniaturized to 96-well microtiter plates and can be employed in </span></span>high throughput screening (HTS), in addition it is robust enough to be applied to microbial fermentation extracts.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 11","pages":"Pages 938-943"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25219278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信